Related Experiment Video
Updated: Sep 5, 2025
3D Planning and Printing of Patient Specific Implants for Reconstruction of Bony Defects
Published on: August 4, 2020
[Financing of complex replacement surgery]
1GFO Kliniken Troisdorf, Hospitalstr. 45, 53840, Troisdorf, Deutschland. Pierre.goebel@gfo-kliniken-troisdorf.de.
Insights
Hip revision arthroplasty presents significant economic challenges due to insufficient reimbursement. Hospitals require high case volumes, expertise, and negotiated fees for financial viability in complex procedures.
Area of Science:
- Orthopaedic Surgery
- Health Economics
Background:
- Hip revision arthroplasty involves complex procedures with substantial economic challenges for hospitals.
- Current reimbursement structures, particularly Diagnosis-Related Groups (DRGs), often fail to cover the costs of advanced implants like modular or custom-made systems.
Purpose of the Study:
- To analyze the economic challenges and reimbursement landscape of hip revision arthroplasty in Germany.
- To highlight the financial impact of recent changes in reimbursement policies on orthopaedic interventions.
Main Methods:
- Analysis of German reimbursement policies for hip revision surgery, including DRG and OPS code changes.
- Evaluation of the economic impact on hospitals performing isolated cup exchanges, stem exchanges, and complete prosthesis revisions.
Main Results:
- Reimbursement for hip revision surgery in Germany has been reduced and differentiated, negatively impacting orthopaedic surgeons.
- The downgrade of the isolated cup exchange DRG (from I46B to I47A) and deletion of OPS codes have created financial burdens.
- Complex revisions are only economically feasible with additional fees, high case numbers, and significant surgical experience.
Conclusions:
- Hip revision arthroplasty is an economically challenging field requiring careful financial management.
- Achieving cost coverage necessitates high patient volumes, specialized expertise, and successful negotiation of supplementary fees.
Background:
In addition to the surgical demands of hip revision arthroplasty, the reimbursement of the different types of interventions represents a major economic challenge for orthopaedic hospitals. With complex revision endoprostheses such as, for example, modular systems or custom-made implants, the flat-rate DRG is usually not sufficient to cover the costs generated and assure sufficient revenue.
Trend:
In Germany, the reimbursement of various replacement interventions in hip revision surgery has been differentiated and reduced in recent years and mostly not in favour of orthopaedic surgeons. Recently, the isolated cup exchange was substantially downgraded from the significantly better rated DRG I46B to the clearly lower rated DRG I47A. Isolated stem exchanges or complete exchanges of the entire endoprosthesis are sometimes only economically affordable for hospitals with supportive reimbursement by means of additional fees. An additional burden for hospitals in recent years has been the repeated deletion of additional OPS codes by insurance companies, which has led to the triggering of an additional fee.
Conclusion:
In summary, hip revision arthroplasty is an economically difficult terrain, in which cost coverage with appropriate reimbursement can only be achieved under the prerequisite of high case numbers, great experience and negotiation of adequate additional fees.
